Selected research
Industry Growth & Trends
Global Cell Culture Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cell Culture Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cell Culture Service market include Danaher, Lonza, WuXi Biologics, Samsung Biologics, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, Evotec and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cell Culture Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cell Culture Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Culture Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Culture Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cell Culture Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cell Culture Service Market by Company
Danaher
Lonza
WuXi Biologics
Samsung Biologics
Charles River Laboratories
Labcorp Drug Development
Eurofins Scientific
Evotec
Catalent
AGC Biologics
ProBioGen
Pharmaron
Takara Bio
AGC Biologics Japan
Thermo Fisher Scientific
Merck KGaA
Sartorius
Cell Culture Service Segment by Type
Primary Cells
Transformed Cells
Self-renewing Cells
Cell Culture Service Segment by Application
Research Institute
Hospital
Others
Cell Culture Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cell Culture Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Primary Cells
- Transformed Cells
- Self-renewing Cells
Applications
- Research Institute
- Hospital
- Others
Companies covered
- Danaher
- Lonza
- WuXi Biologics
- Samsung Biologics
- Charles River Laboratories
- Labcorp Drug Development
- Eurofins Scientific
- Evotec
- Catalent
- AGC Biologics
- ProBioGen
- Pharmaron
- Takara Bio
- AGC Biologics Japan
- Thermo Fisher Scientific
- Merck KGaA
- Sartorius
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cell Culture Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cell Culture Service Market Size by Region (2021-2032)
- 1.4.1 Global Cell Culture Service Market Size by Region (2021-2026)
- 1.4.2 Global Cell Culture Service Market Size by Region (2027-2032)
- 1.5 Key Regions Cell Culture Service Market Size (2021-2032)
- 1.5.1 North America Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cell Culture Service Market Size Growth Rate (2021-2032)
2 Cell Culture Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Primary Cells
- 2.1.2 Transformed Cells
- 2.1.3 Self-renewing Cells
- 2.2 Global Cell Culture Service Market Size by Type
- 2.2.1 Global Cell Culture Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cell Culture Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cell Culture Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cell Culture Service Market Size by Regions
- 2.3.1 North America Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cell Culture Service Market Size Breakdown by Type (2021-2026)
3 Cell Culture Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Research Institute
- 3.1.2 Hospital
- 3.1.3 Others
- 3.2 Global Cell Culture Service Market Size by Application
- 3.2.1 Global Cell Culture Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cell Culture Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cell Culture Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cell Culture Service Market Size by Regions
- 3.3.1 North America Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cell Culture Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cell Culture Service Industry Trends
- 4.2 Cell Culture Service Industry Drivers
- 4.3 Cell Culture Service Industry Opportunities and Challenges
- 4.4 Cell Culture Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cell Culture Service Revenue (2021-2026)
- 5.2 Global Cell Culture Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cell Culture Service Key Company Headquarters & Area Served
- 5.4 Global Cell Culture Service Company, Product Type & Application
- 5.5 Global Cell Culture Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cell Culture Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cell Culture Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Cell Culture Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Danaher
- 6.1.1 Danaher Company Information
- 6.1.2 Danaher Business Overview
- 6.1.3 Danaher Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Danaher Cell Culture Service Product Portfolio
- 6.1.5 Danaher Recent Developments
- 6.2 Lonza
- 6.2.1 Lonza Company Information
- 6.2.2 Lonza Business Overview
- 6.2.3 Lonza Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Lonza Cell Culture Service Product Portfolio
- 6.2.5 Lonza Recent Developments
- 6.3 WuXi Biologics
- 6.3.1 WuXi Biologics Company Information
- 6.3.2 WuXi Biologics Business Overview
- 6.3.3 WuXi Biologics Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 WuXi Biologics Cell Culture Service Product Portfolio
- 6.3.5 WuXi Biologics Recent Developments
- 6.4 Samsung Biologics
- 6.4.1 Samsung Biologics Company Information
- 6.4.2 Samsung Biologics Business Overview
- 6.4.3 Samsung Biologics Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Samsung Biologics Cell Culture Service Product Portfolio
- 6.4.5 Samsung Biologics Recent Developments
- 6.5 Charles River Laboratories
- 6.5.1 Charles River Laboratories Company Information
- 6.5.2 Charles River Laboratories Business Overview
- 6.5.3 Charles River Laboratories Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Charles River Laboratories Cell Culture Service Product Portfolio
- 6.5.5 Charles River Laboratories Recent Developments
- 6.6 Labcorp Drug Development
- 6.6.1 Labcorp Drug Development Company Information
- 6.6.2 Labcorp Drug Development Business Overview
- 6.6.3 Labcorp Drug Development Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Labcorp Drug Development Cell Culture Service Product Portfolio
- 6.6.5 Labcorp Drug Development Recent Developments
- 6.7 Eurofins Scientific
- 6.7.1 Eurofins Scientific Company Information
- 6.7.2 Eurofins Scientific Business Overview
- 6.7.3 Eurofins Scientific Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Eurofins Scientific Cell Culture Service Product Portfolio
- 6.7.5 Eurofins Scientific Recent Developments
- 6.8 Evotec
- 6.8.1 Evotec Company Information
- 6.8.2 Evotec Business Overview
- 6.8.3 Evotec Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Evotec Cell Culture Service Product Portfolio
- 6.8.5 Evotec Recent Developments
- 6.9 Catalent
- 6.9.1 Catalent Company Information
- 6.9.2 Catalent Business Overview
- 6.9.3 Catalent Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Catalent Cell Culture Service Product Portfolio
- 6.9.5 Catalent Recent Developments
- 6.10 AGC Biologics
- 6.10.1 AGC Biologics Company Information
- 6.10.2 AGC Biologics Business Overview
- 6.10.3 AGC Biologics Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AGC Biologics Cell Culture Service Product Portfolio
- 6.10.5 AGC Biologics Recent Developments
- 6.11 ProBioGen
- 6.11.1 ProBioGen Company Information
- 6.11.2 ProBioGen Business Overview
- 6.11.3 ProBioGen Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 ProBioGen Cell Culture Service Product Portfolio
- 6.11.5 ProBioGen Recent Developments
- 6.12 Pharmaron
- 6.12.1 Pharmaron Company Information
- 6.12.2 Pharmaron Business Overview
- 6.12.3 Pharmaron Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pharmaron Cell Culture Service Product Portfolio
- 6.12.5 Pharmaron Recent Developments
- 6.13 Takara Bio
- 6.13.1 Takara Bio Company Information
- 6.13.2 Takara Bio Business Overview
- 6.13.3 Takara Bio Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Takara Bio Cell Culture Service Product Portfolio
- 6.13.5 Takara Bio Recent Developments
- 6.14 AGC Biologics Japan
- 6.14.1 AGC Biologics Japan Company Information
- 6.14.2 AGC Biologics Japan Business Overview
- 6.14.3 AGC Biologics Japan Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 AGC Biologics Japan Cell Culture Service Product Portfolio
- 6.14.5 AGC Biologics Japan Recent Developments
- 6.15 Thermo Fisher Scientific
- 6.15.1 Thermo Fisher Scientific Company Information
- 6.15.2 Thermo Fisher Scientific Business Overview
- 6.15.3 Thermo Fisher Scientific Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Thermo Fisher Scientific Cell Culture Service Product Portfolio
- 6.15.5 Thermo Fisher Scientific Recent Developments
- 6.16 Merck KGaA
- 6.16.1 Merck KGaA Company Information
- 6.16.2 Merck KGaA Business Overview
- 6.16.3 Merck KGaA Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Merck KGaA Cell Culture Service Product Portfolio
- 6.16.5 Merck KGaA Recent Developments
- 6.17 Sartorius
- 6.17.1 Sartorius Company Information
- 6.17.2 Sartorius Business Overview
- 6.17.3 Sartorius Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Sartorius Cell Culture Service Product Portfolio
- 6.17.5 Sartorius Recent Developments
7 North America
- 7.1 North America Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cell Culture Service Market Size by Country (2021-2026)
- 7.3 North America Cell Culture Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cell Culture Service Market Size by Country (2021-2026)
- 8.3 Europe Cell Culture Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cell Culture Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cell Culture Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cell Culture Service Market Size by Country (2021-2026)
- 10.3 South America Cell Culture Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cell Culture Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cell Culture Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst